These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

530 related items for PubMed ID: 11345163

  • 1. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 2. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F, Zago V, Verona J, Muzzio ML, Wikinski R, Schreier L.
    Life Sci; 2006 May 22; 78(26):3074-81. PubMed ID: 16488445
    [Abstract] [Full Text] [Related]

  • 3. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women.
    Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio F, Wikinski R, Schreier L.
    Atherosclerosis; 2004 Nov 22; 177(1):203-10. PubMed ID: 15488885
    [Abstract] [Full Text] [Related]

  • 4. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN.
    J Clin Invest; 1998 Apr 15; 101(8):1581-90. PubMed ID: 9541487
    [Abstract] [Full Text] [Related]

  • 5. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C, Gu Q.
    Nephrology (Carlton); 2009 Aug 15; 14(5):514-20. PubMed ID: 19207863
    [Abstract] [Full Text] [Related]

  • 6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F.
    Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641
    [Abstract] [Full Text] [Related]

  • 7. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.
    Liguori A, Abete P, Hayden JM, Cacciatore F, Rengo F, Ambrosio G, Bonaduce D, Condorelli M, Reaven PD, Napoli C.
    Eur Heart J; 2001 Nov 15; 22(22):2075-84. PubMed ID: 11686665
    [Abstract] [Full Text] [Related]

  • 8. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein.
    Geetha A, Surendran R.
    Pharmazie; 2005 Aug 15; 60(8):609-13. PubMed ID: 16124405
    [Abstract] [Full Text] [Related]

  • 9. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z, Liu B, Zhou J, Zhang Z, Liu Y, Bai H.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct 15; 34(4):704-7. PubMed ID: 14619587
    [Abstract] [Full Text] [Related]

  • 10. Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of alpha-tocopherol supplementation.
    Sampson MJ, Astley S, Richardson T, Willis G, Davies IR, Hughes DA, Southon S.
    Clin Sci (Lond); 2001 Sep 15; 101(3):235-41. PubMed ID: 11524040
    [Abstract] [Full Text] [Related]

  • 11. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES.
    Metabolism; 2006 Sep 15; 55(9):1201-6. PubMed ID: 16919539
    [Abstract] [Full Text] [Related]

  • 12. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity.
    Park KH, Shin DG, Kim JR, Hong JH, Cho KH.
    Int J Mol Med; 2010 Jan 15; 25(1):129-36. PubMed ID: 19956911
    [Abstract] [Full Text] [Related]

  • 13. High density lipoprotein subclasses inhibit low density lipoprotein oxidation.
    Singh K, Chander R, Kapoor NK.
    Indian J Biochem Biophys; 1997 Jun 15; 34(3):313-8. PubMed ID: 9425752
    [Abstract] [Full Text] [Related]

  • 14. Relations of lysophosphatidylcholine in low-density lipoprotein with serum lipoprotein-associated phospholipase A2, paraoxonase and homocysteine thiolactonase activities in patients with type 2 diabetes mellitus.
    Sonoki K, Iwase M, Sasaki N, Ohdo S, Higuchi S, Matsuyama N, Iida M.
    Diabetes Res Clin Pract; 2009 Nov 15; 86(2):117-23. PubMed ID: 19748147
    [Abstract] [Full Text] [Related]

  • 15. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P.
    Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499
    [Abstract] [Full Text] [Related]

  • 16. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ, Braschi S, Willis G, Astley SB.
    Clin Sci (Lond); 2005 Aug 01; 109(2):189-97. PubMed ID: 15853770
    [Abstract] [Full Text] [Related]

  • 17. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
    Valabhji J, McColl AJ, Schachter M, Dhanjil S, Richmond W, Elkeles RS.
    Clin Sci (Lond); 2001 Dec 01; 101(6):659-70. PubMed ID: 11724654
    [Abstract] [Full Text] [Related]

  • 18. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A, de Faria EC, Chantepie S, Chapman MJ.
    Arterioscler Thromb Vasc Biol; 2004 Mar 01; 24(3):526-33. PubMed ID: 14739123
    [Abstract] [Full Text] [Related]

  • 19. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C, Di Giacomo S, Vivenzio A, Isacchi GC, Masella R, Caprari P, Varì R, Tarzia A, Mosiello A, Cantafora A.
    Clin Sci (Lond); 2001 Feb 01; 100(2):191-8. PubMed ID: 11171288
    [Abstract] [Full Text] [Related]

  • 20. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.
    Cominacini L, Pastorino AM, Garbin U, Campagnola M, de Santis A, Davoli A, Faccini G, Bertozzo L, Pasini F, Pasini AF.
    Nutrition; 1994 Feb 01; 10(6):527-31. PubMed ID: 7703599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.